Two cases with generalised bullous cutaneous reactions after COVID‐19 mRNA vaccine Moderna (Spikevax®) and Pfizer-BioNTech (Comirnaty®)

Two cases with generalised bullous cutaneous reactions after COVID‐19 mRNA vaccine Moderna (Spikevax®) and Pfizer-BioNTech (Comirnaty®)

Abstract Bullous cutaneous reactions can be caused by many factors, including vaccines.1 However, among all cutaneous reactions following coronavirus disease 2019 (COVID‐19) mRNA vaccines, bullous reactions are rare. Here, we describe two patients with delayed generalised bullous cutaneous reactions...

Full description

Saved in:
Bibliographic Details
Main Authors: Charlotte E. Rinnooy Kan (Author), Heike Röckmann (Author), Marijke R. vanDijk (Author), Tanuja Ramsaransing (Author), Lieke L. Reubsaet (Author), Elke E. M. Peters (Author), Lydia E. Vos (Author)
Format: Book
Published: Wiley, 2024-03-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items